In observance of Rare Disease Day, a new effort is underway to finally provide answers to the estimated 300 million people ...

This method, known as biomarker testing, has the potential to improve patient outcomes significantly, but its high cost means it's not accessible to everyone. House Bill 1062 aims to change that ...

While electronic exchange of orders and results is commonplace in the commercial lab world, public health labs struggle with inconsistent levels of connectivity.